Adverts

Open Access Articles- Top Results for Bromopride

Bromopride

</th></tr></th></tr>
Bromopride
File:Bromopride.svg
File:Bromopride.png
Systematic (IUPAC) name
4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
Clinical data
AHFS/Drugs.com International Drug Names
  • (Prescription only)
Oral, IM, IV
Pharmacokinetic data
Bioavailability 50 to 75% (oral)
78% (intramuscular)
Protein binding 40%
Metabolism Hepatic
Half-life 4 to 5 hours
Excretion Renal, 10 to 14% unchanged
Identifiers
4093-35-0 7pxN
A03FA04
PubChem CID 2446
DrugBank DB09018 7pxN
ChemSpider 2352 7pxY
UNII 75473V2YZK 7pxY
KEGG D07101 7pxY
ChEMBL CHEMBL399510 7pxY
Chemical data
Formula C14H22BrN3O2
344.248 g/mol
 14pxN (what is this?)  (verify)

Bromopride (INN) is a dopamine antagonist with prokinetic properties widely used as an antiemetic, closely related to metoclopramide. It is not available in the United States.

Bromopride appears to be safe and effective for use in pregnancy.[1]

Indications

Bromopride is indicated in the treatment of nausea and vomiting, including postoperative nausea and vomiting (PONV); gastroesophageal reflux disease (GERD/GORD); and as preparation for endoscopy and radiographic studies of the gastrointestinal tract. The manufacturer also claims it is valuable in, among other indications, hiccups and gastrointestinal adverse effects of radiation therapy.

Adverse effects

Bromopride is generally well tolerated; the most common adverse effects of its use are somnolence and fatigue. Bromopride may rarely cause extrapyramidal symptoms and, as with metoclopramide, may increase prolactin levels.[2]

Chemistry

Bromopride is a substituted benzamide, closely related to metoclopramide.[3] It is identical to metoclopramide except for the presence of a bromine atom where metoclopramide has a chlorine substituent.

Availability

Bromopride is not available in the United States or the United Kingdom. It is marketed in Brazil by Sanofi-Synthélabo under the trade name 'Digesan, by LIBBS under the name Plamet, and as a generic drug.

References

  1. ^ Araújo JR (1981). "Evaluation of bromopride in nausea and vomiting of pregnancy". J Bras Ginecol (in Portuguese) 91 (4): 283–5. 
  2. ^ "Bula do Profissional de Saúde: Bromoprida". Bulário Eletrônico da Anvisa (in Portuguese). Brazilian National Health Surveillance Agency. April 11, 2006. Retrieved 2007-07-23. 
  3. ^ Brodie RR, Chasseaud LF, Darragh A, Lambe RF, Rooney L, Taylor T (1986). "Pharmacokinetics and bioavailability of the anti-emetic agent bromopride". Biopharm Drug Dispos 7 (3): 215–22. PMID 3730521. doi:10.1002/bdd.2510070302.